PASW

+ Watchlist + Portfolio

Ping An Biomedical Co., Ltd.

Regulated industry Sells to businessesTags from an AI model reading the company description.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $0.12
52-Week Range: $0.11 – $1.09
Market Cap: $15.83M
P/E (TTM): —
EPS (TTM): -0.06
Dividend Yield: 0.00%

Advanced Metrics

Price/Book: 1.36
PEG Ratio: —
Return on Equity: -11.35%
Return on Assets: -8.86%
Gross Margin: 9.27%
Operating Margin: 5.60%
Profit Margin: -14.78%
Current Ratio: 2.54
Debt/Equity: 0.13
Total Debt: $10.27M
Free Cash Flow: $-46.39M
Revenue Growth: -47.40%
Earnings Growth: —
Enterprise Value: $19.05M

PASW Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$114.55M	$82.56M	$87.62M	$34.15M
Cost of Revenue	$100.40M	$78.32M	$82.21M	$33.20M
Gross Profit	$14.14M	$4.24M	$5.42M	$949.50K
Selling, General & Admin	$3.11M	$3.60M	$4.85M	$6.30M
Operating Expenses	$2.99M	$3.63M	$5.42M	$15.65M
Operating Income	$11.15M	$612.48K	-$2.04K	-$14.70M
EBITDA	$11.61M	$1.81M	$473.34K	-$14.37M
Pretax Income	$9.63M	$41.69K	-$682.72K	-$14.68M
Income Tax	$2.40M	$1.04M	$601.46K	-$1.86M
Net Income	$7.23M	-$993.94K	-$1.28M	-$12.83M
Diluted EPS	0.35	-0.05	—	—
Diluted Shares	20.50M	20.50M	—	—

PASW Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$1.17M	$591.87K	$130.92K	$1.17M
Receivables	$67.56M	$61.05M	$40.52M	$17.25M
Inventory	$4.63M	$3.19M	$127.30K	$441.90K
Current Assets	$79.04M	$76.57M	$53.31M	$63.70M
Total Assets	$81.95M	$79.84M	$56.85M	$68.41M
Current Liabilities	$77.35M	$85.63M	$63.58M	$23.08M
Total Debt	$35.57M	$42.96M	$10.81M	$10.47M
Total Liabilities	$77.35M	$85.70M	$64.04M	$23.17M
Retained Earnings	$4.45M	-$6.58M	-$8.22M	-$21.05M
Shareholders' Equity	$4.60M	-$5.86M	-$7.19M	$45.24M
Working Capital	$1.69M	-$9.06M	-$10.27M	$40.62M
Net Debt	$34.33M	$41.91M	$9.87M	$8.83M

PASW Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$21.09M	-$6.08M	$14.63M	-$6.43M
Capital Expenditure	-$24.78K	—	—	—
Free Cash Flow	$21.06M	-$6.08M	$14.63M	-$6.43M
Depreciation & Amortisation	$24.65K	$32.76K	$10.24K	$5.58K
Investing Cash Flow	-$30.26M	-$3.37M	$15.00M	$0.00
Financing Cash Flow	$10.24M	$8.87M	-$30.09M	$43.66M
Dividends Paid	-$4.83M	-$9.60M	-$322.41K	$0.00
Net Change in Cash	$1.07M	-$575.74K	-$458.68K	$37.23M

PASW Balance Sheet statement, quarterly periods, in CNY
CNY	Q3 2025
Cash & Equivalents	$1.17M
Receivables	$17.25M
Inventory	$441.90K
Current Assets	$63.70M
Total Assets	$68.41M
Current Liabilities	$23.08M
Total Debt	$10.47M
Total Liabilities	$23.17M
Retained Earnings	-$21.05M
Shareholders' Equity	$45.24M
Working Capital	$40.62M
Net Debt	$8.83M

Market Snapshot

About

Ping An Biomedical is a healthcare and biomedical technology company based in China, operating under the Ping An Insurance Group umbrella. The company focuses on developing medical diagnostics, healthcare services, and biotechnology solutions to support the broader healthcare ecosystem in China and Asia.